VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-1.18%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$496M
AUM Growth
+$22M
(+4.6%)
Cap. Flow
+$35.1M
Cap. Flow
% of AUM
7.06%
Top 10 Holdings %
Top 10 Hldgs %
10.47%
Holding
461
New
27
Increased
142
Reduced
189
Closed
26
Top Buys
Top Sells
| 1 |
OXLC
Oxford Lane Capital
OXLC
|
$6.67M |
| 2 |
ECC
Eagle Point Credit Co
ECC
|
$5.43M |
| 3 |
ANDX
Andeavor Logistics LP
ANDX
|
$2.66M |
| 4 |
BlackRock Floating Rate Income Strategies Fund
FRA
|
$2.25M |
| 5 |
MVC
MVC Capital, Inc.
MVC
|
$1.95M |
Sector Composition
| 1 | Financials | 24.1% |
| 2 | Real Estate | 16.28% |
| 3 | Energy | 14.42% |
| 4 | Healthcare | 8.59% |
| 5 | Materials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
276
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $151K | 0.03% |
20,197
-1,125
| -5% | -$8.41K |
|
277
KalVista Pharmaceuticals
KALV
$796M
| $147K | 0.03% |
12,688
-707
| -5% | -$8.19K |
|
278
uniQure
QURE
$985M
| $137K | 0.03% |
3,476
-194
| -5% | -$7.65K |
|
279
ProQR Therapeutics
PRQR
$258M
| $132K | 0.03% |
22,938
-1,278
| -5% | -$7.35K |
|
280
Adverum Biotechnologies
ADVM
$73.9M
| $127K | 0.03% |
2,335
-130
| -5% | -$7.07K |
|
281
AnaptysBio
ANAB
$613M
| $127K | 0.03% |
3,620
-202
| -5% | -$7.09K |
|
282
Microsoft
MSFT
$3.68T
| $120K | 0.02% |
861
+286
| +50% | +$39.9K |
|
283
Abeona Therapeutics
ABEO
$353M
| $110K | 0.02% |
1,955
-109
| -5% | -$6.13K |
|
284
Alibaba
BABA
$323B
| $98K | 0.02% |
588
-554
| -49% | -$92.3K |
|
|
CBIO
285
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $97K | 0.02% |
226
-12
| -5% | -$5.15K |
|
|
PHAS
286
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $91K | 0.02% |
21,738
-1,211
| -5% | -$5.07K |
|
287
Bank of America
BAC
$369B
| $66K | 0.01% |
2,250
-171
| -7% | -$5.02K |
|
288
Verizon
VZ
$187B
| $62K | 0.01% |
1,026
| – | – |
|
289
American Express
AXP
$227B
| $46K | 0.01% |
385
| – | – |
|
290
Lockheed Martin
LMT
$108B
| $46K | 0.01% |
119
| – | – |
|
291
Itaú Unibanco
ITUB
$76.6B
| $45K | 0.01% |
7,066
+1,004
| +17% | +$6.39K |
|
292
Elevance Health
ELV
$70.6B
| $42K | 0.01% |
175
| – | – |
|
293
Merck
MRK
$212B
| $41K | 0.01% |
+511
| New | +$41K |
|
294
Synopsys
SNPS
$111B
| $41K | 0.01% |
301
+38
| +14% | +$5.18K |
|
295
Progressive
PGR
$143B
| $40K | 0.01% |
513
-250
| -33% | -$19.5K |
|
296
PayPal
PYPL
$65.2B
| $40K | 0.01% |
389
+205
| +111% | +$21.1K |
|
297
RTX Corp
RTX
$211B
| $40K | 0.01% |
462
| – | – |
|
298
Starbucks
SBUX
$97.1B
| $40K | 0.01% |
448
-53
| -11% | -$4.73K |
|
299
America Movil
AMX
$59.1B
| $38K | 0.01% |
2,578
-2,725
| -51% | -$40.2K |
|
300
Veeva Systems
VEEV
$44.7B
| $38K | 0.01% |
251
| – | – |
|